Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease

T Wang, X Liu, J Guan, S Ge, MB Wu, J Lin… - European Journal of …, 2019 - Elsevier
Complex diseases (eg, Alzheimer's disease) or infectious diseases are usually caused by
complicated and varied factors, including environmental and genetic factors. Multi-target …

[HTML][HTML] Intracerebral injection of extracellular vesicles from mesenchymal stem cells exerts reduced Aβ plaque burden in early stages of a preclinical model of …

CA Elia, M Tamborini, M Rasile, G Desiato, S Marchetti… - Cells, 2019 - mdpi.com
Bone marrow Mesenchymal Stem Cells (BM-MSCs), due to their strong protective and anti-
inflammatory abilities, have been widely investigated in the context of several diseases for …

What place does molecular topology have in today's drug discovery?

R Zanni, M Galvez-Llompart… - Expert Opinion on …, 2020 - Taylor & Francis
Introduction Most methods in molecular and drug design are currently based on
physicochemical descriptors. However, molecular topology, which relies on topological …

[HTML][HTML] Marine fungal metabolite butyrolactone I prevents cognitive deficits by relieving inflammation and intestinal microbiota imbalance on aluminum trichloride …

Y Nie, J Yang, L Zhou, Z Yang, J Liang, Y Liu… - Journal of …, 2022 - Springer
Background Mounting evidences indicate that oxidative stress, neuroinflammation, and
dysregulation of gut microbiota are related to neurodegenerative disorders (NDs) …

Hypoxia and the kynurenine pathway: implications and therapeutic prospects in Alzheimer's disease

OS Adeyemi, OJ Awakan, LB Afolabi… - Oxidative Medicine …, 2021 - Wiley Online Library
Neurodegenerative diseases (NDs) like Alzheimer's disease, multiple sclerosis, amyotrophic
lateral sclerosis, Parkinson's disease, and Huntington's disease predominantly pose a …

[HTML][HTML] Metformin improves memory via AMPK/mTOR-dependent route in a rat model of Alzheimer's disease

RAM Mehraban, P Babaei, K Rohampour… - Iranian Journal of …, 2024 - ncbi.nlm.nih.gov
Objective (s): Metformin, as an insulin sensitizer, is a familiar antidiabetic drug. Increasing
evidence points to metformin's protective effects against Alzheimer's disease (AD). However …

[HTML][HTML] Use of QSAR global models and molecular docking for developing new inhibitors of c-src tyrosine kinase

R Ancuceanu, B Tamba, CS Stoicescu… - International journal of …, 2019 - mdpi.com
A prototype of a family of at least nine members, cellular Src tyrosine kinase is a
therapeutically interesting target because its inhibition might be of interest not only in a …

[HTML][HTML] Insights from nature: a review of natural compounds that target protein misfolding in vivo

C Terry - Current Research in Biotechnology, 2020 - Elsevier
Protein misfolding is fundamental to a number of human disorders including Alzheimer's
disease, prion diseases, Parkinson's disease and type 2 diabetes mellitus. To date, there …

阿尔茨海默病动物模型的研究进展

盛哲津, 李利妹 - 实验动物与比较医学, 2022 - slarc.org.cn
阿尔茨海默病(Alzheimer's disease, AD) 是最常见的老年性神经退行性疾病之一,
严重威胁着老年人的健康. 目前被批准用于治疗AD 的药物只能缓解AD 的症状, 不能治愈AD …

Allosteric modulators of potential targets related to Alzheimer's Disease: a Review

GM Silva, MP Barcelos, JGC Poiani… - …, 2019 - Wiley Online Library
Among neurodegenerative disorders, Alzheimer's disease (AD) is the most common type of
dementia, and there is an urgent need to discover new and efficacious forms of treatment for …